Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anorak Ventures is an active U.S.-based seed-stage venture capital firm, not a biotech, pharma, or healthcare operating company. The firm was founded in 2016 and describes itself as investing in pre-seed and seed-stage technology companies, with offices in San Francisco and Los Angeles. Its focus is broad technology investing rather than drug development, and public descriptions emphasize frontier and differentiated technology businesses rather than life sciences R&D. As a result, Anorak Ventures does not have a therapeutic pipeline, clinical programs, or healthcare product portfolio in the way a biotech analyst would typically expect.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anorak Ventures.